CONMED (CNMD) vs TransMedics Group (TMDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CONMED (CNMD) has outperformed TransMedics Group (TMDX) over the past year, losing 3.0% versus a loss of 33.1%. Over five years, TMDX leads with a +197.6% price change compared with -68.2% for CNMD. TransMedics Group is the larger company by market cap ($2.74 billion vs $1.35 billion), about 2.0 times the size.
On valuation, CONMED trades at a lower forward P/E (9.4x vs 35.0x for TransMedics Group). CONMED pays a dividend yielding 0.44%, while TransMedics Group does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | TMDX |
|---|---|---|
| Share price | $45.11 | $79.00 |
| Market cap | $1.35B | $2.74B |
| 1-day change | +1.99% | -2.55% |
| YTD return | +11.11% | -35.06% |
| 1-year return | -3.03% | -33.08% |
| 5-year return | -68.24% | +197.55% |
| P/E ratio (TTM) | 24.38 | 20.47 |
| Forward P/E | 9.43 | 35.05 |
| EPS (TTM) | $1.85 | $3.86 |
| Dividend yield | 0.44% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | — | $605.49M |
| Revenue growth (YoY) | — | +37.13% |
| Net income (latest FY) | — | $190.29M |
| Gross margin | — | 59.92% |
| Operating margin | — | 17.93% |
| Net margin | — | 31.43% |
| 52-week high | $53.66 | $156.00 |
| 52-week low | $31.44 | $60.11 |
| Distance from 52-week high | -15.93% | -49.36% |
| Analyst consensus | none | buy |
| Avg. price target upside | +0.86% | +26.35% |
| Average volume | 493.66K | 820.41K |
| Shares outstanding | 29.95M | 34.68M |
| Employees | 3,900 | 898 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TransMedics Group is about 2.0 times larger than CONMED by market value ($2.74B vs $1.35B).
- CNMD has outperformed TMDX by 30.1 percentage points over the past year.
- The two companies sit in different sectors: CONMED in Health Care and TransMedics Group in Healthcare.
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
About TransMedics Group
TMDX stock →TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Healthcare · Medical Devices · 898 employees
CNMD vs TMDX FAQ
Which is bigger, CONMED or TransMedics Group?
TransMedics Group (TMDX) is larger, with a market capitalization of $2.74B compared with $1.35B for CONMED (CNMD).
Which stock has performed better over the past year, CNMD or TMDX?
CNMD returned -3.03% over the past 12 months, compared with -33.08% for TMDX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNMD or TMDX?
TMDX has the lower trailing P/E at 20.5, versus 24.4 for CNMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CONMED or TransMedics Group?
CONMED pays a dividend yielding 0.44%, while TransMedics Group does not currently pay a regular dividend.
Are CONMED and TransMedics Group in the same industry?
No. CONMED is in the Health Care sector, while TransMedics Group is in Healthcare.